Healthcare Services

Hepatitis Diagnostic Testing Market: Key Developments Driving Growth

April 22, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Hepatitis Diagnostic Tests Market Between 2026 And 2030?

The hepatitis diagnostic tests market size has observed significant expansion in recent years. This market is expected to expand from $4.93 billion in 2025 to $5.21 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.7%. The growth witnessed in the past can be attributed to the widespread implementation of hepatitis screening programs, a surge in laboratory testing volumes, heightened public awareness concerning viral hepatitis, better accessibility to diagnostic infrastructure, and the establishment of standardized testing protocols.

The market for hepatitis diagnostic tests is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $6.72 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.6%. Key factors driving this expansion during the forecast period include the escalating demand for decentralized diagnostics, increased investments in sophisticated molecular testing, the broadening availability of home-based testing options, a heightened emphasis on detecting diseases early, and greater uptake in regions with limited resources. Significant trends expected throughout this period involve the rising adoption of rapid diagnostic tests, the expanding application of molecular diagnostic technologies, the increasing incorporation of automated laboratory systems, the proliferation of point-of-care testing solutions, and a stronger emphasis on timely and precise diagnosis.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

What Key Drivers Are Fueling The Growth Of The Hepatitis Diagnostic Tests Market?

An anticipated increase in blood transfusions and donations is projected to fuel the expansion of the hepatitis diagnostic test market moving ahead. These two processes are closely linked, involving individuals voluntarily offering their blood. This donated blood is then collected, screened, and later given to patients needing extra blood components for treating various medical conditions or to replenish blood lost from surgeries, accidents, or illnesses. To ensure patient safety, hepatitis diagnostic tests are employed for comprehensive blood screening prior to both donation and transfusion. Illustratively, data from August 2023, provided by the UK organization Royal College of Pathologists, indicates that blood transfusion represents the most common procedure for hospitalized individuals, with approximately 2 million blood components distributed and transfused in England each year, incurring costs exceeding £300 ($390.69) million. Consequently, the growing frequency of blood transfusions and donations is a key driver for the hepatitis diagnostic test market.

Which Segment Categories Are Included In The Hepatitis Diagnostic Tests Market Segment Analysis?

The hepatitis diagnostic tests market covered in this report is segmented –

1) By Test Type: Blood Tests, Imaging Tests, Liver Biopsy

2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDTs), Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Test (INAAT), Other Technologies

3) By End User: Hospitals, Diagnostic Laboratories, Blood Bank, Other End Users

Subsegments:

1) By Blood Tests: Serological Tests, Polymerase Chain Reaction (PCR) Tests, Enzyme-Linked Immunosorbent Assays (ELISA)

2) By Imaging Tests: Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI)

3) By Liver Biopsy: Percutaneous Biopsy, Transjugular Biopsy, Laparoscopic Biopsy

What Trends Are Influencing The Hepatitis Diagnostic Tests Market?

Leading companies in the hepatitis diagnostic test market are focused on developing innovative automated immunoassays, such as Elecsys HCV Duo, to ensure dependable customer service. Automated immunoassays are laboratory methods that utilize automation systems and specialized instruments to perform every stage of the immunoassay procedure, including sample handling, reagent mixing, incubation, detection, and result calculation. For instance, in July 2023, Roche Diagnostics India, an India-based biotechnology research company, introduced Elecsys HCV Duo. This marks India’s first commercially available fully automated immunoassay, which facilitates the simultaneous and independent assessment of hepatitis C virus (HCV) antigen and antibody levels from a single human plasma or serum sample. This advancement also enables single specimen testing and streamlines the diagnostic algorithm, reducing the need for multiple patient visits for further tests and potentially easing the burden on the healthcare system’s testing capabilities.

Who Are The Active Companies Shaping The Hepatitis Diagnostic Tests Market?

Major companies operating in the hepatitis diagnostic tests market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Roche Diagnostics, Quest Diagnostics Incorporated, Grifols S.A, Hologic Inc., BioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Co. Ltd., QIAGEN N.V., DiaSorin S.p.A., Randox Laboratories Ltd., Luminex Corporation, Fujirebio Diagnostics Inc., Trivitron Healthcare Private Limited, Trinity Biotech plc, MP Biomedicals LLC, R-Biopharm AG, Creative Diagnostics, InBios International Inc., Dia.Pro Diagnostic Bioprobes srl, DIALAB GmbH

Get The Full Hepatitis Diagnostic Tests Market Report:

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Which Region Has The Greatest Market Share In The Hepatitis Diagnostic Tests Market?

North America was the largest region in the hepatitis diagnostic tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis diagnostic tests market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Hepatitis Diagnostic Tests Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Browse Through More Reports Similar to the Global Hepatitis Diagnostic Tests Market 2026, By The Business Research Company

Viral Hepatitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Liver Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Infectious Disease Diagnostics Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795